Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.

Ghislat G, Rahman T, Ballester PJ

Open source

DOI
10.3390/biom10111570
Published
2020 Nov 19
Container
Biomolecules
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biom10111570,
  title = {Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.},
  author = {Ghislat G and Rahman T and Ballester PJ},
  year = {2020},
  journal = {Biomolecules},
  doi = {10.3390/biom10111570},
  url = {https://doi.org/10.3390/biom10111570}
}

RIS

TY  - JOUR
TI  - Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.
AU  - Ghislat G
AU  - Rahman T
AU  - Ballester PJ
PY  - 2020
JO  - Biomolecules
DO  - 10.3390/biom10111570
UR  - https://doi.org/10.3390/biom10111570
ER  -

APA

G, G., T, R., & PJ, B. (2020). Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.. Biomolecules. https://doi.org/10.3390/biom10111570

Source records